Dopexamine

• Description :

  Dopexamine is a β2 adrenergic receptor agonist.

• Product Name Alternative :

  FPL 60278

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H312-H332

• Target :

  Adrenergic Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Cardiovascular Disease; Endocrinology

• Assay Protocol :

  https://www.medchemexpress.com/dopexamine.html

• Smiles :

  OC1=C(O)C=CC(CCNCCCCCCNCCC2=CC=CC=C2)=C1

• Molecular Formula :

  C22H32N2O2

• Molecular Weight :

  356.50

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

• References & Citations :

  [1]Bangash MN, et al. Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow. Crit Care. 2013 Mar 28;17 (2) :R57.|[2]Hollenberg SM. Dopexamine: immunomodulatory, hemodynamic, or both? Crit Care. 2013 May 13;17 (3) :143.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• CAS Number :

  [86197-47-9]